BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 760K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

7 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The design of potent and selective inhibitors of DPP-4: optimization of ADME properties by amide replacements.EBI
Santhera Pharmaceuticals (Switzerland)
From lead to preclinical candidate: optimization of beta-homophenylalanine based inhibitors of dipeptidyl peptidase IV.EBI
Santhera Pharmaceuticals (Switzerland)
Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV.EBI
Santhera Pharmaceuticals (Switzerland)
In silico fragment-based discovery of DPP-IV S1 pocket binders.EBI
Santhera Pharmaceuticals
Fragment-Based Discovery of Novel Potent Sepiapterin Reductase Inhibitors.EBI
Gr�Nenthal
Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their useBDB
TBA
Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-a converting enzyme (TACE/ADAM-17).BDB
China Pharmaceutical University